Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGVHD

Donor lymphocyte infusion (DLI) is an option for relapsed hematologic malignancies or incomplete chimerism of non-malignant diseases following allogeneic hematopoietic cell transplantation (HCT). We analyzed the incidence of acute graft versus host disease (aGVHD) in patients treated with DLI. From...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Bone Marrow Transplant
Päätekijät: He, Fiona, Warlick, Erica, Miller, Jeffrey S., MacMillan, Margaret, Verneris, Michael R., Cao, Qing, Weisdorf, Daniel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4972636/
https://ncbi.nlm.nih.gov/pubmed/27064686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2016.63
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia